Literature DB >> 30465135

Enzyme-catalyzed regio-selective demethylation of papaverine by CYP105D1.

Chen Shen1, Wanli Zhao1, Xuming Liu2, Jihua Liu3,4.   

Abstract

OBJECTIVES: To investigate the regio-selective demethylation of papaverine by CYP105D1 and develop a whole-cell biocatalytic system for the preparative synthesis of 6-O-demethyl-papaverine.
RESULTS: CYP105D1 from Streptomyces griseus ATCC 13273 was used for the regioselective demethylation of papaverine at C-6 using putidaredoxin reductase (PDR) and putidaredoxin (Pdx) as the electron transport system. The Km value of CYP105D1 towards papaverine was estimated to be 92.24 μM. Furthermore, a CYP105D1-based whole-cell system was established in E. coli BL21(DE3). The whole cell biotransformation condition was optimized as 25 °C, pH 7.5, 8 g (cell dry weight) L-1 whole cell biomass and 3% (v/v) PEG-200 as cosolvent. Under the optimal condition, the conversion yield of papaverine reached to 61.15% within 24 h.
CONCLUSIONS: The selective demethylation of papaverine by CYP105D1 was accomplished. The CYP105D1-based whole-cell biocatalyst has a potential used for the efficient synthesis of 6-O-demethyl-papaverine.

Entities:  

Keywords:  Biocatalysis; Cytochrome P450; O-demethylation; Papaverine; Whole-cell biotransformation

Mesh:

Substances:

Year:  2018        PMID: 30465135     DOI: 10.1007/s10529-018-2626-0

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  2 in total

1.  Characterization of high-H2O2-tolerant bacterial cytochrome P450 CYP105D18: insights into papaverine N-oxidation.

Authors:  Bashu Dev Pardhe; Hackwon Do; Chang-Sook Jeong; Ki-Hwa Kim; Jun Hyuck Lee; Tae-Jin Oh
Journal:  IUCrJ       Date:  2021-06-29       Impact factor: 4.769

Review 2.  Streptomycetes as platform for biotechnological production processes of drugs.

Authors:  Simona Barbuto Ferraiuolo; Marcella Cammarota; Chiara Schiraldi; Odile Francesca Restaino
Journal:  Appl Microbiol Biotechnol       Date:  2021-01-04       Impact factor: 4.813

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.